Read + Share
Amedeo Smart
Independent Medical Education
Lee A, Jin HO, Masudul Haque M, Kim HY, et al. Synergism of a novel MCL1 downregulator, acriflavine, with navitoclax (ABT263) in triplenegative breast cancer, lung adenocarcinoma and glioblastoma multiforme. Int J Oncol 2022;60.PMID: 34913076
Email
LinkedIn
Facebook
Twitter
Privacy Policy